Wednesday 23 January 2013

FDA approves Exjade in patients with genetic blood disorder

* Exjade approved for non-transfusion-dependent thalassemia

Source: http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/6YIVKeIs398/novartis-exjade-idUSL1N0ASEXC20130123

computer desk with hutch t shirt printer bush office furniture

No comments:

Post a Comment